Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090859076> ?p ?o ?g. }
- W2090859076 endingPage "10" @default.
- W2090859076 startingPage "1" @default.
- W2090859076 abstract "Background and Aim . CC chemokine ligand 18 (CCL18) promotes malignant behaviors of various human cancer types. However, its involvement in human prostate cancer has not been fully elucidated. The aim of this study was to investigate the role of CCL18 in PCa. Methods . Expression of CCL18 at mRNA and protein levels was detected using real-time qRT-PCR and immunohistochemistry analysis. We analyzed the associations of CCL18 expression with clinical features of human PCa. The effects of PCa cell migration, invasion, and apoptosis were tested. The efficiency of CCL18 on prostate tumor growth was assessed in a subcutaneous xenograft model. Results . CCL18 expression was upregulated (both<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.01</mml:mn></mml:math>) in PCa tissues compared with those in noncancerous prostate tissues. CCL18 upregulation was correlated with high Gleason score (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn>0.034</mml:mn></mml:math>) of patients with PCa. rCCL18 stimulation in PCa cells promoted cell migration and invasion but decreased DU145 cells apoptosis rate. Furthermore, subcutaneous homografts models showed the increased tumor growth and tumor vascularization with the CCL18 stimulation, and the expression of Ki67, PCNA, and CD31 in CCL18 stimulation mice was also significantly increased. Conclusions . Our data offer the convincing evidence that the upregulation of CCL18 may be involved in the malignant progression of PCa." @default.
- W2090859076 created "2016-06-24" @default.
- W2090859076 creator A5012938558 @default.
- W2090859076 creator A5013024003 @default.
- W2090859076 creator A5013187242 @default.
- W2090859076 creator A5019216175 @default.
- W2090859076 creator A5022610561 @default.
- W2090859076 creator A5029290303 @default.
- W2090859076 creator A5031864023 @default.
- W2090859076 creator A5041941283 @default.
- W2090859076 creator A5048471761 @default.
- W2090859076 creator A5054147216 @default.
- W2090859076 creator A5059287343 @default.
- W2090859076 creator A5059618028 @default.
- W2090859076 creator A5076773213 @default.
- W2090859076 creator A5088394087 @default.
- W2090859076 date "2014-01-01" @default.
- W2090859076 modified "2023-10-16" @default.
- W2090859076 title "CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer" @default.
- W2090859076 cites W1480357432 @default.
- W2090859076 cites W1607875782 @default.
- W2090859076 cites W1980038658 @default.
- W2090859076 cites W1987558378 @default.
- W2090859076 cites W1995483790 @default.
- W2090859076 cites W2001316090 @default.
- W2090859076 cites W2001717792 @default.
- W2090859076 cites W2003985632 @default.
- W2090859076 cites W2031597127 @default.
- W2090859076 cites W2046283885 @default.
- W2090859076 cites W2068675451 @default.
- W2090859076 cites W2086001732 @default.
- W2090859076 cites W2091844375 @default.
- W2090859076 cites W2125550503 @default.
- W2090859076 cites W2125893332 @default.
- W2090859076 cites W2128627731 @default.
- W2090859076 cites W2136166312 @default.
- W2090859076 cites W2136433362 @default.
- W2090859076 cites W2139181115 @default.
- W2090859076 cites W2161817637 @default.
- W2090859076 cites W4242973457 @default.
- W2090859076 doi "https://doi.org/10.1155/2014/230183" @default.
- W2090859076 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4150478" @default.
- W2090859076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25197632" @default.
- W2090859076 hasPublicationYear "2014" @default.
- W2090859076 type Work @default.
- W2090859076 sameAs 2090859076 @default.
- W2090859076 citedByCount "40" @default.
- W2090859076 countsByYear W20908590762015 @default.
- W2090859076 countsByYear W20908590762016 @default.
- W2090859076 countsByYear W20908590762017 @default.
- W2090859076 countsByYear W20908590762018 @default.
- W2090859076 countsByYear W20908590762019 @default.
- W2090859076 countsByYear W20908590762020 @default.
- W2090859076 countsByYear W20908590762021 @default.
- W2090859076 countsByYear W20908590762022 @default.
- W2090859076 countsByYear W20908590762023 @default.
- W2090859076 crossrefType "journal-article" @default.
- W2090859076 hasAuthorship W2090859076A5012938558 @default.
- W2090859076 hasAuthorship W2090859076A5013024003 @default.
- W2090859076 hasAuthorship W2090859076A5013187242 @default.
- W2090859076 hasAuthorship W2090859076A5019216175 @default.
- W2090859076 hasAuthorship W2090859076A5022610561 @default.
- W2090859076 hasAuthorship W2090859076A5029290303 @default.
- W2090859076 hasAuthorship W2090859076A5031864023 @default.
- W2090859076 hasAuthorship W2090859076A5041941283 @default.
- W2090859076 hasAuthorship W2090859076A5048471761 @default.
- W2090859076 hasAuthorship W2090859076A5054147216 @default.
- W2090859076 hasAuthorship W2090859076A5059287343 @default.
- W2090859076 hasAuthorship W2090859076A5059618028 @default.
- W2090859076 hasAuthorship W2090859076A5076773213 @default.
- W2090859076 hasAuthorship W2090859076A5088394087 @default.
- W2090859076 hasBestOaLocation W20908590761 @default.
- W2090859076 hasConcept C104317684 @default.
- W2090859076 hasConcept C121608353 @default.
- W2090859076 hasConcept C126322002 @default.
- W2090859076 hasConcept C127561419 @default.
- W2090859076 hasConcept C13373296 @default.
- W2090859076 hasConcept C142724271 @default.
- W2090859076 hasConcept C157081693 @default.
- W2090859076 hasConcept C170493617 @default.
- W2090859076 hasConcept C2776438761 @default.
- W2090859076 hasConcept C2779723316 @default.
- W2090859076 hasConcept C2780192828 @default.
- W2090859076 hasConcept C502942594 @default.
- W2090859076 hasConcept C55493867 @default.
- W2090859076 hasConcept C71924100 @default.
- W2090859076 hasConcept C86803240 @default.
- W2090859076 hasConceptScore W2090859076C104317684 @default.
- W2090859076 hasConceptScore W2090859076C121608353 @default.
- W2090859076 hasConceptScore W2090859076C126322002 @default.
- W2090859076 hasConceptScore W2090859076C127561419 @default.
- W2090859076 hasConceptScore W2090859076C13373296 @default.
- W2090859076 hasConceptScore W2090859076C142724271 @default.
- W2090859076 hasConceptScore W2090859076C157081693 @default.
- W2090859076 hasConceptScore W2090859076C170493617 @default.
- W2090859076 hasConceptScore W2090859076C2776438761 @default.
- W2090859076 hasConceptScore W2090859076C2779723316 @default.
- W2090859076 hasConceptScore W2090859076C2780192828 @default.